Molecular Determinants of Osseointegration in Implant-Supported Prostheses: A Narrative Review of Gene Expression Signatures, Signaling Pathways, and Bioinformatic Insights
Cureus · 07.07.2026
DOI: 10.7759/cureus.112219 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 07.07.2026. Verfasst von Cristian Villamizar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dentistry, Universidad Santo Tomás, Bucaramanga, COL. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Osseointegration is a biologically complex process that determines the long-term success of implant-supported prostheses. Advances in molecular biology have shown that gene expression programs and signaling networks, rather than mechanical fixation alone, govern bone healing and implant integration. Yet, these molecular determinants are still seldom used to guide clinical decisions, which continue to rely on mechanical and histologic assessments. This narrative review addresses that gap by analyzing the molecular determinants of osseointegration through five connected perspectives: the cellular cascade that follows implant placement; the principal osteogenic signaling pathways (bone morphogenetic protein (BMP), Wnt/β-catenin, nuclear factor kappa B (NF-κB), and Runt-related transcription factor 2 (RUNX2)); transcriptomic signatures across the inflammatory, repair, and remodeling phases; bioinformatic gene regulatory and protein-protein interaction networks associated with implant success or failure; and the influence of implant surface properties on the molecular response. Across these perspectives, osteogenic and angiogenic genes such as RUNX2, collagen type I alpha 1 chain (COL1A1), bone gamma-carboxyglutamate protein (BGLAP), and vascular endothelial growth factor A (VEGFA) are consistently linked to successful integration, whereas sustained inflammatory and osteoclastogenic signatures such as IL6, tumor necrosis factor (TNF), matrix metalloproteinase-9 (MMP9), and nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1) characterize failure. The review then considers how this knowledge may be translated into gene expression-based biomarkers, peri-implant crevicular fluid monitoring, patient risk stratification, and precision implant therapy, and identifies the main barriers to clinical adoption of an emerging implantogenomics framework.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dentistry, Universidad Santo Tomás, Bucaramanga, COL.
- Dentistry, Universidad de Carabobo, Valencia, VEN.
- Dentistry, Universidad del Magdalena, Santa Marta, COL.
- Dentistry, Universidad Nacional Experimental de los Llanos Centrales Rómulo Gallegos, San Juan de los Morros, VEN.
- Dentistry, Universidad Nororiental Privada Gran Mariscal de Ayacucho, Barcelona, VEN.
- Dentistry, Universidad Del Salvador, San Salvador, SLV.
Zitieren
APA
Villamizar, C., Medina Barreto, J., Ascanio Lara, S. L., Gamez Vicuña, A., Tokatli, J., Lopez Alas, E. E., & Rodriguez, L. S. (2026). Molecular Determinants of Osseointegration in Implant-Supported Prostheses: A Narrative Review of Gene Expression Signatures, Signaling Pathways, and Bioinformatic Insights. Cureus. https://doi.org/10.7759/cureus.112219
Vancouver
Villamizar C, Medina Barreto J, Ascanio Lara SL, Gamez Vicuña A, Tokatli J, Lopez Alas EE, et al. Molecular Determinants of Osseointegration in Implant-Supported Prostheses: A Narrative Review of Gene Expression Signatures, Signaling Pathways, and Bioinformatic Insights. Cureus. 2026. doi:10.7759/cureus.112219
BibTeX
@article{Villamizar2026,
author = {Villamizar, Cristian and Medina Barreto, Joanith and Ascanio Lara, Sara L and Gamez Vicuña, Astrid and Tokatli, Jessica and Lopez Alas, Estela E and Rodriguez, Luisana S},
title = {Molecular Determinants of Osseointegration in Implant-Supported Prostheses: A Narrative Review of Gene Expression Signatures, Signaling Pathways, and Bioinformatic Insights},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.112219}
}
EUVIMED